APOE E4 Reference Standard
CBPA0143
詢(xún) 價(jià)
索取COA
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫(kù)
| Introduction | |
| Format | Genomic DNA |
| Description | APOE include Lipoprotein Glomerulopathy and Hyperlipoproteinemia, Type Iii. Among its related pathways are Neuroscience and Lipoprotein metabolism. Gene Ontology (GO) annotations related to this gene include protein homodimerization activity and signaling receptor binding. |
| Technical Data | |
| Gene | APOE |
| APOE E4 | AA Change：p.Cys130Arg |
| DNA Change：NM 000041.4:c.388T>C | |
| Chr position (GRCh37)：NC_000019.9:g.45411941T>C | |
| Allelic Frequency：50% | |
| Zygosity：Heterozygous | |
| APOE E3 | AA Change：p.Arg176Cys |
| DNA Change：NM 000041.2:c.526C>T | |
| Chr position (GRCh37)：NC000019.9:g45412079C>T | |
| Allelic Frequency：0% | |
| Zygosity：Wild Type | |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
Figure 1. APOE (c.388T>C)
Figure 2. APOE (c.526C>T) |
| Storage | 2-8°C |
| Expiry | 36 months from the date of manufacture |
